妇科疾病影像学(19):胃肠外间质瘤(eGIST)的临床与超声特征
这项回顾性多中心研究从欧洲九家妇科肿瘤中心数据库检索35例经组织学确诊的eGIST患者术前超声资料,由各中心研究者按IOTA与MUSA术语回顾图像和报告。eGIST通常为较大的实性、分叶状或不规则、血流丰富且无后方声影的盆腹腔肿瘤,超声报告多能正确判为恶性病变。
要点
- eGIST多为盆腹腔较大实性肿瘤(中位最大径79 mm),分叶状或不规则,血流丰富(color score 3或4者占88.6%),无后方声影(88.6%)。
- 实性eGIST中回声均匀者仅25.8%且均为低回声;不均匀者39.1%为混合回声、60.9%含囊性区。
- 发现与肠壁无连接、非起源于子宫或附件的盆腹腔实性富血供肿瘤时,应高度怀疑eGIST。
核心结论
- 超声上eGIST通常为实性、不均匀的盆腹腔分叶状肿瘤,呈混合回声、可伴或不伴囊性区,血流丰富且无后方声影。
- 具备上述特征且与肠壁无连接、非起源于子宫或附件的肿瘤,高度提示eGIST。
研究设计与样本
- 回顾性多中心研究,数据来自欧洲九家大型妇科肿瘤中心数据库。
- 纳入35例经组织学确诊eGIST且术前行超声检查的患者,由各中心一名研究者按预设超声评估表回顾存储图像和超声报告。
- 采用国际卵巢肿瘤分析(IOTA)与子宫形态超声评估(MUSA)工作组术语描述病变,并记录临床、手术和病理信息。
关键影像表现/征象
- 绝大多数eGIST为腹膜内病变(32例,91.4%),其余为腹膜后(2例,5.7%)或腹膜前(1例,2.9%);最常见部位为腹部(23例,65.7%),其次为盆腔(12例,34.3%)。
- 肿瘤通常较大(中位最大径79 mm)、为实性(31例,88.6%),多房实性者较少(4例,11.4%)。
- 实性肿瘤回声均匀者8/31(25.8%),均为低回声;不均匀者23例,其中混合回声9/23(39.1%)、含囊性区14/23(60.9%)。
- 形态以分叶状(19例,54.3%)或不规则(10例,28.6%)为主;血流丰富(color score 3或4)31例(88.6%),无后方声影31例(88.6%)。
- 基于图像模式识别,超声报告通常将eGIST正确归类为恶性病变(32例,91.4%);最常考虑的鉴别诊断依次为eGIST(16例,45.7%)、原发性卵巢癌(5例,14.3%)、淋巴瘤(2例,5.7%)和带蒂子宫肌瘤(2例,5.7%)。
诊断标准与关键数值
- 未设定统一诊断阈值;采用IOTA与MUSA术语对病变进行描述性分类。
- 基于图像模式识别,超声报告将32/35(91.4%)eGIST正确归类为恶性病变。
临床应用与阅片要点
- 阅片时注意肿瘤与肠壁无连接、非起源于子宫或附件这一组合特征,结合实性、不均匀、分叶状或不规则、富血供及无后方声影等表现,可将eGIST列入鉴别诊断。
- eGIST最常被误诊为原发性卵巢癌(5例,14.3%),其次为淋巴瘤(2例,5.7%)和带蒂子宫肌瘤(2例,5.7%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To describe the clinical and sonographic characteristics of extragastrointestinal stromal tumors (eGISTs).
METHODS: This was a retrospective multicenter study. The data of patients with a histological diagnosis of eGIST who had undergone preoperative ultrasound examination were retrieved from the databases of nine large European gynecologic oncology centers. One investigator from each center reviewed stored images and ultrasound reports, and described the lesions using the terminology of the International Ovarian Tumor Analysis and Morphological Uterus Sonographic Assessment groups, following a predefined ultrasound evaluation form. Clinical, surgical and pathological information was also recorded.
RESULTS: Thirty-five women with an eGIST were identified; in 17 cases, the findings were incidental, and 18 cases were symptomatic. Median age was 57 years (range, 21-85 years). Tumor marker CA 125 was available in 23 (65.7%) patients, with a median level of 23 U/mL (range, 7-403 U/mL). The vast majority of eGISTs were intraperitoneal lesions (n = 32 (91.4%)); the remaining lesions were retroperitoneal (n = 2 (5.7%)) or preperitoneal (n = 1 (2.9%)). The most common site of the tumor was the abdomen (n = 23 (65.7%)), and less frequently the pelvis (n = 12 (34.3%)). eGISTs were typically large (median largest diameter, 79 mm) solid (n = 31 (88.6%)) tumors, and were less frequently multilocular-solid tumors (n = 4 (11.4%)). The echogenicity of solid tumors was uniform in 8/31 (25.8%) cases, which were all hypoechogenic. Twenty-three solid eGISTs were non-uniform, either with mixed echogenicity (9/23 (39.1%)) or with cystic areas (14/23 (60.9%)). The tumor shape was mainly lobular (n = 19 (54.3%)) or irregular (n = 10 (28.6%)). Tumors were typically richly vascularized (color score of 3 or 4, n = 31 (88.6%)) with no shadowing (n = 31 (88.6%)). Based on pattern recognition, eGISTs were usually correctly classified as a malignant lesion in the ultrasound reports (n = 32 (91.4%)), and the specific diagnosis of eGIST was the most frequent differential diagnosis (n = 16 (45.7%)), followed by primary ovarian cancer (n = 5 (14.3%)), lymphoma (n = 2 (5.7%)) and pedunculated uterine fibroid (n = 2 (5.7%)).
CONCLUSIONS: On ultrasound, eGISTs were usually solid, non-uniform pelvic or abdominal lobular tumors of mixed echogenicity, with or without cystic areas, with rich vascularization and no shadowing. The presence of a tumor with these features, without connection to the bowel wall, and not originating from the uterus or adnexa, is highly suspicious for eGIST. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Ambrosio M, Testa AC, Moro F, et al. Imaging in gynecological disease (19): clinical and ultrasound features of extragastrointestinal stromal tumors (eGIST). Ultrasound Obstet Gynecol. 2020. PMID: 31909545. doi:10.1002/uog.21968
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。